T2 Biosystems, Inc
TTOO
TTOO was delisted on the 11th of February, 2025.
40 hedge funds and large institutions have $8.23M invested in T2 Biosystems, Inc in 2023 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 12 increasing their positions, 4 reducing their positions, and 8 closing their positions.
1,724% more capital invested
Capital invested by funds: $451K → $8.23M (+$7.78M)
200% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 4
163% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 8
102% more call options, than puts
Call options by funds: $131K | Put options by funds: $65K
43% more funds holding
Funds holding: 28 → 40 (+12)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.53M |
| 2 |
BlackRock
New York
|
+$951K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$618K |
| 4 |
Jane Street
New York
|
+$148K |
| 5 |
BBA
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
|
+$140K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$380K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$67K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$32.3K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$31.7K |
| 5 |
IWM
IHT Wealth Management
Chicago,
Illinois
|
-$14.2K |
TTOO Hedge Fund Activity: Q3 2023 in Review
40 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q3 2023, worth a combined $8.23M — up 1,724% from $451K a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new TTOO positions and 8 closed out — a net gain of 13 holders — while 12 added to existing stakes and 4 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $1.53M. The largest seller was GSA Capital Partners, cutting an estimated $380K.
- 40 institutional investors held T2 Biosystems, Inc (TTOO) as of Q3 2023, up from 28 in Q2 2023.
- Funds reported $8.23M of T2 Biosystems, Inc stock for Q3 2023, up 1,724% quarter-over-quarter.
- 21 funds opened new T2 Biosystems, Inc positions in Q3 2023 and 8 closed out, a net change of +13 holders.
- The largest T2 Biosystems, Inc buyer in Q3 2023 was Vanguard Group, an estimated $1.53M added.
- The largest T2 Biosystems, Inc seller in Q3 2023 was GSA Capital Partners, an estimated $380K sold.
Based on aggregated 13F filings for Q3 2023.